News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Clinical - Pre-Clinical
Spring Bank Pharmaceuticals, Inc. Presents Data On STING Agonist SB 11285 At The AACR Special Conference On Tumor Immunology And Immunotherapy 10/20/2016
SAGE Therapeutics (SAGE) And Collaborators Publish New Pre-Clinical Data In Neuropharmacology Demonstrating A Novel Metabotropic Mechanism Of Sage 10/20/2016
Cantargia To Present New Data From Preclinical Studies With CAN04 In Non-Small Cell Lung Cancer 10/20/2016
Cynata's Technology Significant Efficacy In Preclinical Asthma Study 10/17/2016
Acorda (ACOR) Release: Data From Clinical And Preclinical Trials Of CVT-301 For Treatment Of OFF Periods In Parkinson's Disease Published In Science Translational Medicine 10/13/2016
Cellerant Therapeutics, Inc. Presents Preclinical Data Showing Promise Of A Novel Differentiated Target On Leukemic Stem Cells 10/11/2016
Organovo (ONVO) Introduces 3D Bioprinted Human Liver As Leading Therapeutic Tissue In Preclinical Development 10/5/2016
Innovus Pharma Initiates Pre-Clinical And Clinical Program Evaluating The Safety And Efficacy Of Vesele With Sildenafil (Viagra) 10/5/2016
Axsome (AXSM) Announces Publication Of Research Showing AXS-02 Inhibits Pain In Animal Model Of Complex Regional Pain Syndrome 10/4/2016
OSE Immunotherapeutics To Present The Preclinical Data Of Its New Checkpoint Inhibitor Effi-DEM On SIRP-a/CD47 Strategic Pathway At The 2016 Immune Checkpoint Inhibitors Conference 10/4/2016
Asana Medical's Preclinical Study Indicates Promising Solution To Treat Ulcerative Colitis 10/4/2016
Spotlight Innovation Launches Development Of STL-182 To Treat Spinal Muscular Atrophy 10/4/2016
CohBar Advances First-In-Class Mitochondria Based Therapeutic To IND-Enabling Activities 9/30/2016
Karyopharm (KPTI) Publishes Preclinical Data In Nature Demonstrating Selinexor’s Potential In KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC) 9/29/2016
Karyopharm (KPTI) Publishes Preclinical And Phase 1 Clinical Data For Selinexor In Ovarian Cancer In Clinical Cancer Research Publication 9/28/2016
Peregrine (PPHM) Presents Preclinical Data Demonstrating PS-Targeting Antibodies Significantly Enhance The Anti-Tumor Activity Of Multiple Checkpoint Targeting Agents In Model Of Triple Negative Breast Cancer (TNBC) 9/27/2016
Infinity Pharma (INFI) Presents Initial Clinical And New Preclinical Data On IPI-549 At Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference 9/27/2016
MiNA Announces Presentation Of Pre-Clinical Data Supporting On-Target Mechanism Of Action Of Clinical Candidate MTL-CEBPA 9/27/2016
Viking Therapeutics (VKTX) Presents Positive Proof-Of-Concept Data For VK0214 In In Vivo Model Of X-Linked Adrenoleukodystrophy (X-ALD) At The 86th Annual Meeting Of The American Thyroid Association 9/26/2016
Allakos Antibodies Shown To Inhibit Fibrosis, A Common Cause Of Organ Failure 9/26/2016
MabVax Therapeutics Humab-5B1 Based Diagnostic Imaging And Radioimmunotherapy Programs Featured At The 2016 World Molecular Imaging Congress 9/26/2016
BerGenBio AS: New BGB324 Study Points To Novel Mechanism To Enhance Immunotherapy Efficacy 9/26/2016
Turing Announces Development Of New Drug Candidates For Toxoplasmosis 9/22/2016
Proteostasis (PTI) Announces Scientific Presentations On New Data At 30th Annual North American Cystic Fibrosis Conference 9/22/2016
Avacta Group Release: Positive Results From First Preclinical In-Vivo Studies Of Affimer Therapeutics 9/22/2016
Renova Therapeutics Release: The Journal Of Clinical Investigation Insight Publishes Preclinical Results Of Urocortin 2 Gene Transfer In Mouse Models Of Insulin Resistance 9/22/2016
Regen BioPharma Receives Positive Data From Preclinical Studies Of Its Small Molecule NR2F6 Modulators 9/20/2016
Sutro Biopharma ADCs Targeting CD74 Suppress Tumors In Multiple Malignant Cell Lines And Animal Models Of Multiple Myeloma And Non-Hodgkin Lymphoma 9/19/2016
Cephalogics Announces Results Of In Vivo Studies That Demonstrate The Ability Of Its Compact Perfusion Imaging System To Identify And Track Brain Perfusion Deficits 9/19/2016
Global Blood Therapeutics (GBT) Announces Publication Of Preclinical Results Supporting GBT440 Program For Hypoxemic Pulmonary Disorders 9/15/2016
Boston Children's Hospital Release: Antibiotic Gel Squirted Into The Ear Could Provide A One-Dose Cure For Ear Infections 9/15/2016
ArQule, Inc. (ARQL)Announces Publication Of Manuscript Highlighting Preclinical Activity Of FGFR Inhibitor, ARQ 087, In Peer Reviewed Journal 9/15/2016
Onxeo Announces First Outcomes Of Livatag Preclinical Plan 9/13/2016
Probiodrug AG Release: Combination Therapy With Glutaminyl Cyclase (QC) Inhibitor PQ912 And pGlu-Abeta Specific Antibody PBD-C06 Shows Clear Additive Effects In Reducing pGlu-Abeta As Well As Abeta In Alzheimer-Mouse Model 9/13/2016
ContraVir Reports New CRV431 Data Highlighting Synergistic Activity With CMX157 Against Hepatitis B 9/12/2016
Omeros (OMER)’ MASP-2 Antibody Preserves Brain Tissue And Function In Stroke Models 9/8/2016
Interferon Shows Promise As Flu Therapy, Francis Crick Institute in London Study 9/7/2016
Tarix Orphan Receives Orphan Drug Status For TXA127 For Genetic Skin Disorder Recessive Dystrophic Epidermolysis Bullosa (RDEB) 9/7/2016
Biocryst (BCRX) Announces Positive Study Results For BCX4430 Delayed Treatment Of Ebola Virus Infection In A Non-Human Primate Model 9/7/2016
Onxeo: Combination Of Asidna And PARP Inhibitors Demonstrates Synergistic Effect, Bypasses Genetic Restriction 9/7/2016
Promising New Findings For Probiodrug AG's Glutaminyl Cyclase - Inhibitor In An Inflammation Animal Model 9/7/2016
Cyclacel Pharma (CYCC)’s CYC065 Demonstrates Promising Activity In MYCN-Addicted Neuroblastoma In Preclinical Data Presented At Childhood Cancer 2016 9/6/2016
Can Pomegranates Protect The Brain From Dementia? University of New South Wales Reveals 9/1/2016
Biogen (BIIB)'s Experimental Alzheimer’s Drug Shows Promise in Human Trials 9/1/2016
Researchers Target Gut Bacteria To Reduce Weight Gain, Vanderbilt University Study 8/29/2016
European Society of Cardiology Congress Poster Session Reveals Results From Pre-Clinical Study Using CardioCell's Stem Cells for Chronic Ischemic Cardiomyopathy 8/29/2016
European Society of Cardiology Congress Presentation Reveals Results From Pre-Clinical Study Using CardioCell's Stem Cells For Acute Myocardial Infarction (AMI) 8/29/2016
Vybion, Inc. Release: Novel Gene Therapy Drug For Huntington's Disease 8/24/2016
Idera Pharma (IDRA) Presents The Novel Mechanism Of Action Of Its Third Generation Antisense Technology 8/24/2016
US Phytotherapy Reports Successful Pre-Clinical Testing Of PROACT-D 8/24/2016
Regeneron (REGN) Announces Agreement With BARDA For The Manufacturing And Testing Of New Antibodies Against MERS Virus 8/22/2016
DeuteRx Enters Clinical Stage Development With DRX-065 8/22/2016
ContraVir To Release New CRV431 Data Highlighting Potential Synergy With CMX157 Against Hepatitis B 8/22/2016
NYU Langone Medical Center Release: Antibiotic Treatment Increased Risk For Type 1 Diabetes In Animal Study 8/22/2016
iX Biopharma Announces Development Of Supplement For Jet Lag 8/17/2016
GlycoMimetics, Inc. (GLYC) Announces Publication Of Preclinical Data Showing Drug Candidate GMI-1271 Reduces Inflammatory Responses After Heart Attack 8/16/2016
Basilea (BSLN.SW) Ends Further Development of Inhaled Antibiotic BAL30072 8/15/2016
Tissue Regeneration Therapeutics Inc. Engineered Mesenchymal Stromal Cells Advance Monoclonal Antibody Therapy 8/15/2016
Novogen Limited (NVGN) Submits Investigational New Drug (IND) Application To The US FDA For Cantrixil In Ovarian Cancer 8/11/2016
iX Biopharma Is Developing Its Next Drug In Pain Management 8/10/2016
Veritas Pharma Inc Reaches Important Scientific Milestone; Animal Studies Fully Underway To Evaluate The Safety And Effectiveness Of Cannabis Strains 8/10/2016
Oregon State University Release: Walnuts A Key Food To Improve Metabolism In Obese Mice 8/9/2016
Phytecs Expands Research Slate; Preclinical Data Indicates Its Fluorinated CBD Exhibits Greater Potency Than CBD In Models Of Psychiatric Disorders 8/9/2016
Cyclacel Pharmaceuticals, Inc. (CYCC)’s CYC065 Demonstrates Promising Activity In Uterine Serous Carcinoma In Preclinical Data Published By Independent Academic Researchers 8/2/2016
REGENXBIO's Gene Therapy for Hunter Syndrome Nabs FDA's 'Rare Pediatric Disease' Status 8/2/2016
Addex Therapeutics (ADXN.SW) ADX71441 Demonstrates Positive Results In Highly Translational Preclinical Model Of Spasticity 7/27/2016
Viking Therapeutics (VKTX) Announces Positive Top-Line Results From Proof-Of-Concept Study Of VK0214 In In Vivo Model Of X-Linked Adrenoleukodystrophy (X-ALD) 7/26/2016
Sangamo (SGMO) Announces New Gene Therapy Clinical Development Program for Treatment Of Hemophilia A 7/26/2016
Synaffix Achieves Significantly Improved Therapeutic Index Compared To Both FDA-Approved ADCS And Expands Its Scientific Advisory Board 7/20/2016
Elusys Therapeutics, Inc. Announces That Manuscripts For Its Anthrax Antitoxin, ANTHIM (Obiltoxaximab) Injection, Have Been Accepted For Publication 7/20/2016
MedImmune (AZN) Release: New CELL Study Presents Groundbreaking Pre-Clinical Work: Developing Immune Therapy To Potentially Treat Serious Influenza A 7/20/2016
Alcobra (ADHD) Granted European Orphan Drug Designation For Metadoxine In Fragile X Syndrome 7/19/2016
Inovio Biomedical Corporation Deploys DNA-Based Monoclonal Antibody Technology In Quest To Cure HIV 7/14/2016
YiSheng BioPharma And The United States Army Medical Research Institute Of Infectious Diseases Announce Positive Animal Results Of Vaccine Against Ebola Virus 7/14/2016
Fangyuan Pharma Plans Trials Of New-To-China Antibiotic 7/13/2016
Matinas BioPharma Announces Presentation Of Cryptococcal Meningitis Preclinical Data Of MAT2203 At AIDS-Associated Mycosis Meeting 2016 7/13/2016
Organovo (ONVO) And Roche (RHHBY) Researchers Publish Data Demonstrating Superiority Of 3D Bioprinted Human Liver Tissues In Assessing Drug-Induced Toxicity 7/11/2016
Global Blood Therapeutics (GBT) Announces Publication Of Preclinical GBT440 Results In British Journal Of Haematology That Support Sickle Cell Disease (SCD) Program 7/8/2016
Preclinical Study Validates Science Behind AlloSource's AlloStem Cellular Bone Allograft 7/7/2016
Heat Biologics Announces “Cancer Immunology Research” Publication Featuring Its Compact Platform Technology 7/7/2016
Biocryst (BCRX) Receives Additional NIAID Funding To Advance Development Of BCX4430 To Treat Hemorrhagic Fever Virus Diseases 7/5/2016
Verastem (VSTM) Release: Study Published In Nature Medicine Highlights Potential Role Of FAK Inhibition In Pancreatic Cancer 7/5/2016
Strekin AG Announces The Presentation Of Key STR001 Data At The Conference On Molecular Biology Of Hearing And Deafness, Cambridge UK 7/1/2016
New Preclinical Data Show Potential Of Dicerna (DRNA) GalXC Subcutaneous Delivery Platform As RNAi Drug Discovery Engine 6/29/2016
Immune Pharma Release: New Data Suggests Improved Tumor Response For The Combination of AZIXA and Immune Checkpoint Inhibitors in The Treatment of Cancer 6/28/2016
Entasis Presents Data Supporting The Potential Clinical Utility Of ETX2514, A Next-generation Beta-lactamase Inhibitor, At ASM Microbe 2016 6/28/2016
Tarix Orphan Announces Positive Results With TXA127 In Animal Model Of Dystrophic Epidermolysis Bullosa (DEB) 6/27/2016
PAVmed (PAVMU) Successfully Completes CarpX Pre-Clinical Study 6/24/2016
NYU Langone Medical Center Release: Compound Shown To Reduce Brain Damage Caused By Anesthesia In Animal Model 6/23/2016
Cerulean Pharma Inc. (CERU) Announces Publication In Cancer Research 6/22/2016
Compugen Ltd. (CGEN) Discloses Lead Therapeutic Candidate For CGEN-15029 Immuno-Oncology Program 6/22/2016
A1M Pharma Select Research Toxicology Centre For Preclinical Toxicology Studies On RMC-035 Novel Pre-Eclampsia Drug 6/22/2016
Inovio Pharma (INO)'s DNA Vaccine For Zika Virus Induces Robust Immune Responses In Preclinical Study 6/22/2016
Dipexium Pharmaceuticals (DPRX)' Locilex Microbiology Data Presented At American Society for Microbiology Microbe 2016 Conference 6/21/2016
Seres Therapeutics Presents New Data At American Society for Microbiology Microbe 2016, Including Characterization Of SER-262, The Rationally-Designed, Fermented Microbiome Therapeutic Candidate For Primary Clostridium Difficile Infection 6/21/2016
Gilead (GILD) Presents Preliminary Data On Bictegravir, An Investigational Integrase Strand Transfer Inhibitor For The Treatment Of HIV 6/20/2016
NEMUS Bioscience Announces Enhanced Ocular Tissue Concentration By The Proprietary Prodrug Of Tetrahydrocannabinol (NB1111) - Associated With A Superior Decline In Intra-Ocular Pressure (IOP) In An Animal Model 6/17/2016
Exemplar Genetics To Present On Novel Research Models For Oncology At The World Preclinical Congress 6/16/2016
Therapix Filed An Application With The FDA To Approve An "Orphan" Designation For The Drug Developed Based On The Entourage Technology For Treating Tourette's Syndrome 6/15/2016
twoXAR Completes Initial Studies Of New Rheumatoid Arthritis Drug Candidates 6/14/2016
VeroScience Is Pleased To Support Independent Research From The Laboratory Of Dr. Defronzo And Team At UT Health Science Center, San Antonio 6/13/2016
DBV Tech Announces Publication Of Preclinical Data In JACI Suggesting EPIT Provides Sustained Protection Against Anaphylaxis 6/13/2016
Cytori Therapeutics (CYTX) Cell Therapy Leads To Improved Function And Reduced Scar Tissue In A Urinary Injury Model 6/10/2016
Alzeca Biosciences’ ADx Imaging Technology Shows Positive Results in Early Detection Of Alzheimer's 6/7/2016
AMO Pharma Presents Pre-Clinical Data Showing AMO-01 Successfully Inhibits Activated Pathway Associated With Fragile X Syndrome 6/7/2016
ASCO2016: Nektar Therapeutics (NKTR) Release: Preclinical Data Presented At ASCO 2016 Annual Meeting Demonstrate That Single-Agent NKTR-214 Produces A Large Increase In Tumor-Infiltrating Lymphocytes To Provide Durable Anti-Tumor Activity 6/7/2016
ASCO2016: Acetylon Pharmaceuticals Collaborators Publish ASCO Abstracts Demonstrating Immunomodulatory Properties Of Ricolinostat In Preclinical Melanoma Models 6/3/2016
Novavax (NVAX) Announces New Seasonal Combination Respiratory Vaccine Program 6/3/2016
Onxeo Announces Development Of Beleodaq Oral Formulation Opening New Opportunities For Its HDAC Inhibitor 6/2/2016
Biotech Holdings Ltd. (BIOHF) Announces Positive Preclinical Results On ProCell Probiotic Cell Therapy For Critical Limb Ischemia 6/2/2016
Vium Closes Technology Gap In Preclinical Research To Accelerate Drug Development 6/2/2016
ChromaDex, Inc. Release: University Researchers Show Vitamin Nicotinamide Riboside Is An Effective Tool For Managing The Negative Effects Of Obesity And Diabetes 6/1/2016
BioSpecifics Technologies Corporation (BSTC) Announces Publication Of Encouraging Data For Uterine Fibroid Treatment With CCH In American Journal Of Obstetrics & Gynecology 5/31/2016
Nanobiotix Establishes Promising Preclinical Proof-Of-Concept In Immuno Oncology 5/31/2016
Shenyang Research Institute Selects Provantis Preclinical Software Solution For Chinese Drug Safety Evaluation Center 5/26/2016
GlycoMimetics, Inc. (GLYC) Announces Publication Of New Preclinical Data With GMI-1271 In Science Translational Medicine 5/26/2016
Viamet Receives Orphan Drug Designation From The FDA For VT-1598 For The Treatment Of Coccidioidomycosis 5/25/2016
Reviva Pharma Presented RP5063 Preclinical Efficacy Results For Pulmonary Arterial Hypertension At American Thoracic Society Conference 2016 5/20/2016
Regen BioPharma Announces ucVax: Universal Donor Cancer Cellular Immunotherapy 5/19/2016
Anavex (AVXL) Announces Positive Preclinical Data For ANAVEX 2-73 In Infantile Spasms 5/18/2016
Fate Therapeutics (FATE) Announces Preclinical Data Highlighting Persistent Effector Function Of Allogeneic Natural Killer Cell Cancer Immunotherapy 5/16/2016
TopiVert Completes TOP1630 Preclinical Development 5/16/2016
NovoCure To Present New Preclinical Data Showing Additive Efficacy Of Tumor Treating Fields And PD-1 Inhibitors At The American Association Of Immunologists’ Annual Meeting 2016 5/13/2016
Biostage Successfully Regenerates Esophagus In Groundbreaking Pre-Clinical Work With Mayo Clinic; Data Provides 'Proof Of Concept' To Seek FDA Approval For Clinical Trials 5/12/2016
Dicerna (DRNA) Reports Potent Preclinical Activity With GalNAc-DsiRNA-EX Conjugates 5/11/2016
IIT Research Institute Release: Zika Mouse Model Using Current Strain Enhances Quest For New Vaccines And Treatments 5/10/2016
IIT Research Institute Release: Zika Mouse Model Using Current Strain Enhances Quest For New Vaccines And Treatments 5/10/2016
Sangamo (SGMO) Presents Recent Developments From Research And ZFP Therapeutic Programs In Multiple Presentations At Annual Meeting Of The American Society Of Gene And Cell Therapy 5/9/2016
Dimension Therapeutics Announces Preclinical Data From Bayer-Partnered Hemophilia A Program At American Society For Gene And Cell Therapy (ASGCT) Annual Meeting 5/9/2016
uniQure (QURE) Presents Preclinical Data On AAV Re-Administration, Regulated Gene Expression And Total Brain Transduction At ASGCT 5/9/2016
GTx, Inc. (GTXI) Announces Presentation Of Preclinical Data Demonstrating The Ability Of Sards To Degrade And Inhibit The Androgen Receptor At The American Urological Association Annual Meeting 5/9/2016
Cytori Therapeutics (CYTX) Reports Preliminary Preclinical Data Supporting Use Of Cytori Cell Therapy For Both The Prevention And Treatment Of Hypertrophic Scars 5/5/2016
Relmada Therapeutics Announces Results Of In Vivo Study Showing d-Methadone Has Antidepressant-like Effects 5/4/2016
Acetylon Pharmaceuticals Publishes New Mechanism For The Treatment Of Sickle Cell Disease/Beta-Thalassemia With Selective HDAC1/2 Inhibition In Plos One 5/4/2016
Can-Fite BioPharma (CFBI) To Present Data On Cf602 In The Treatment Of Erectile Dysfunction At American Urological Association's Annual Meeting 5/2/2016
Eleven Biotherapeutics (EBIO) To Present Data At The Association for Research in Vision & Ophthalmology 2016 Annual Meeting 4/29/2016
ThromboGenics NV (TBGNF) Release: New Ocriplasmin Research Findings Presented At Upcoming Association for Research in Vision & Ophthalmology 2016 Annual Meeting In Seattle 4/27/2016
Exemplar Genetics Release: Game-Changing Animal Research Models Offer Superior Translational Research And Better Predictive Efficacy 4/27/2016
Independent Rat Study Finds 54% Oral Insulin Relative Bioavailability Using Tamarisk's MxBA Platform Technology 4/26/2016
NeuroVive (NVP) Starts Preclinical TBI Program In Collaboration With University of Pennsylvania 4/26/2016
Arbutus Biopharma (ABUS) Presents Data From Combination Activity Studies Of HBV Drug Candidates 4/22/2016
DelMar Pharma Release: FDA Grants Orphan Drug Designation For VAL-083 In Ovarian Cancer 4/21/2016
Merrimack (MACK) Unveils Its Latest Antibody Directed Nanotherapeutic, MM-310, At The 2016 AACR Annual Meeting 4/21/2016
Affimed (AFMD) Presents Data On AFM13-Mediated Innate/Adaptive Immune Crosstalk At The AACR Annual Meeting 2016 4/21/2016
PDS Life Sciences Now Proven Market Leader For SEND Submissions 4/21/2016
Affimed (AFMD) Presents Data On EGFRwt and EGFRvIII-Targeting NK- And T-Cell Tandabs At The AACR Annual Meeting 2016 4/21/2016
vTv Therapeutics Presents Data On Two Diabetes Candidates At Keystone Symposia On New Therapeutics For Diabetes And Obesity 4/20/2016
Syros Pharmaceuticals Presents New Data Demonstrating Significant Anti-Tumor Activity Of Its Selective CDK7 Inhibitor In Preclinical Models Of Acute Myeloid Leukemia 4/20/2016
Acetylon Pharmaceuticals Announces The Presentation Of Preclinical Data At AACR Supporting The Use Of Selective HDAC6 Inhibition To Modulate Chronic Lymphocytic Leukemia (CLL) Immunobiology 4/20/2016
CTI BioPharma Release: Preclinical Data Presented At AACR Indicate Pacritinib's Potential To Eradicate Therapy-Resistant Leukemia Stem Cells Residing In Bone Marrow Microenvironment 4/20/2016
Karyopharm (KPTI) Presents Data Demonstrating The Potential Of Nuclear Export Protein Exportin 1 (XPO1) Inhibition In The Treatment Of Traumatic Brain Injury 4/20/2016
Curis (CRIS) And Aurigene Discovery Technologies Limited Present Preclinical Data From Multiple Programs At AACR Annual Meeting 4/20/2016
Immune Design Corporation (IMDZ) Presents New Preclinical Data On Advances Of Two Separate Intratumoral Approaches At The AACR Annual Meeting 2016 4/20/2016
Peregrine (PPHM) Release: Preclinical Data Presented At AACR Annual Meeting Demonstrate Enhanced Therapeutic Benefit Of Combining A Ps-Targeting Antibody With Anti-Pd-1 Therapy In Models Of Triple Negative Breast Cancer (TNBC) 4/20/2016
Celsion (CLSN) Presents Compelling Data At AACR 2016 Demonstrating Synergistic Anti-Cancer Effect Of GEN-1 IL-12 Immunotherapy Plus Avastin And Doxil 4/19/2016
Halozyme (HALO) Expands Oncology Pipeline With Two Compounds Designed For Activity In The Tumor Microenvironment 4/19/2016
BioLineRx Announces Presentation Of Detailed Mechanism Of Action Data For Lead Oncology Platform At AACR 2016 4/19/2016
Tocagen Inc. Presents Positive Preclinical, Proof-Of-Mechanism Data At The AACR Annual Meeting 4/19/2016
Combinations Of Viralytics Ltd (VLA.AX) CAVATAK And Checkpoint Immunotherapy Demonstrate Anti-Cancer Activity In Preclinical Lung Cancer And Melanoma Studies 4/19/2016
TRANSGENE (ENX:TNG) Presents Pre-Clinical Data At AACR On A New Generation Oncolytic Viral Immunotherapy Armed With An Anti-PD1 Monoclonal Antibody 4/19/2016
Arrowhead Pharma (ARWR) Presents Preclinical Data On Renal Cell Carcinoma Program At AACR 2016 4/19/2016
Ariad (ARIA) Announces Results Of Preclinical Studies On AP32788 At The Annual Meeting Of AACR 4/19/2016
Euclises Pharmaceuticals To Present Preclinical Efficacy Results At AACR 4/19/2016
Infinity Pharmaceuticals Inc. (INFI) Release: IPI-549 Alters The Immune-Suppressive Microenvironment And Enhances The Activity Of Checkpoint Inhibitors In Preclinical Models 4/18/2016
Compugen Ltd. (CGEN) Achieves Preclinical Milestone In Cancer Immunotherapy Collaboration With Bayer (BAY) 4/18/2016
DelMar Pharma's VAL-083 Demonstrates Promise In The Treatment Of Non-Small Cell Lung Cancer And Ovarian Cancer 4/18/2016
Nektar Therapeutics (NKTR) Release: Preclinical Data Presented At AACR Demonstrate That Combining NKTR-214 With Checkpoint Blockade Is Superior To Dual Checkpoint Inhibition In Increasing Clonality Of The T Cell Receptor (TCR) Repertoire And T Cell Tumor Infiltration 4/18/2016
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present REOLYSIN Preclinical Research At The 2016 AACR Annual Meeting 4/18/2016
BerGenBio AS Presents New Data Demonstrating That BGB324 Enhances Checkpoint Inhibitor Blockade 4/18/2016
Tolero Pharmaceuticals Presents Data Demonstrating AXL Inhibition Leads To A Reversal Of A Mesenchymal Phenotype Sensitizing Cancer Cells To Targeted Agents And Immuno-Oncology Therapies 4/18/2016
Syros Pharmaceuticals Presents Data Demonstrating Significant Anti-Cancer Activity Of SY-1425 In Preclinical Models Of Acute Myeloid Leukemia 4/18/2016
Asana Biosciences To Provide First Presentation Of Pre-Clinical Data On Its Novel ERK 1/2 Inhibitor Program At The AACR Annual Meeting 4/15/2016
Kadmon To Present Preclinical Data Demonstrating That Its Novel Immuno-Oncology Compound Achieves Long-Lasting And Persistent Antitumor Immunity 4/15/2016
Clementia Release: Positive Effects Of Palovarotene On Spontaneous Heterotopic Ossification, Mobility, And Skeletal Growth In Mouse Models Of FOP Reported In Journal Of Bone And Mineral Research 4/14/2016
ProMetic Life Sci (PFSCF.PK) Confirms PBI-4050's Anti-Fibrotic Effect In Nash Model And On Human Hepatic Stellate Cells 4/14/2016
Arbutus Biopharma (ABUS) Presents Data On HBV Capsid Assembly Inhibitor AB-423 At EASL 2016 4/14/2016
Cytori Therapeutics (CYTX) To Present Preliminary Safety And Efficacy Preclinical Data At The 2016 American Burn Association Meeting 4/14/2016
Assembly Biosciences To Present Data At The International Liver Congress 2016 That Supports Advancing Its CpAM Candidates Into HBV Clinical Trials 4/13/2016
CohBar Announces Preclinical Proof-Of-Principle Publication For SHLP Mitochondrial-Derived Peptides And Their Role In Metabolic Regulation And Cell Viability 4/12/2016
Antegrin Therapeutics Announces Publication Of Preclinical Data In Pancreatic Fibrosis 4/12/2016
Can-Fite BioPharma (CFBI) Announces New Pre-Clinical Data For CF602 Demonstrating Statistically Significant Full Recovery From Erectile Dysfunction After A Single Dose 4/11/2016
NewPhase Successfully Completed Small Mammal Pre-Clinical Trials Of A Cancer Treatment That Transforms Cancer To A Treatable Chronic Ailment 4/11/2016
Curis (CRIS) Announces Presentation Of Preclinical Data From CUDC-907, CA-170 And PD-L1/TIM-3 Antagonist And CA-4948 Programs At AACR Annual Meeting 4/11/2016
Earth Science Tech Announces Positive Results From First Pre-Clinical Study On New Hampshire Participate #1 Of Dysfunctional Veterans With PTSD (Posttraumatic Stress Disorder) Using ETST High Grade Hemp CBD (Cannabidiol) 4/11/2016
Verseon (VSN.L) Presents Further Trial Data On The Low Bleeding Risk Of Its Family Of Preclinical Anti-Coagulant Drugs At BioEurope Conference 4/11/2016
NovoCure To Present New Preclinical Data On Tumor Treating Fields At AACR Annual Meeting 2016 4/7/2016
EnGeneIC Pty Ltd Announces Publication Of Late-Stage Canine Brain Cancer Study Results In PLOS ONE 4/7/2016
Can-Fite BioPharma (CFBI) Reports 2015 Financial Results & Provides Clinical Pipeline Update 4/1/2016
Arbutus Biopharma (ABUS) To Present Preclinical HBV Data At EASL 2016 3/31/2016
Atreca Announces Presentation Of Preclinical Data For Antibody Discovery Program 3/31/2016
Theranexus: Preclinical Results Published In The Specialist Medical Journal Sleep 3/30/2016
Ironwood (IRWD) To Present Clinical And Preclinical Data On sGC Stimulators At Upcoming Scientific Conferences 3/30/2016
Galmed Pharmaceuticals Release: Aramchol Demonstrates Significant Anti-Fibrotic Effect In A Pre-Clinical Model Of Fatty Liver Disease 3/30/2016
Cincinnati Children's Hospital Medical Center Release: New Mouse Model for Acute Myeloid Leukemia Opens Door To Research, Possible Treatments 3/30/2016
Discarded GlaxoSmithKline (GSK) Drug Fights Two Disease-Causing Viruses In Lab 3/29/2016
ContraVir's CMX157 Bests Gilead (GILD)'s Tenofovir AF (TAF) Against Hep B Virus in Head-to-Head In-Vitro Study 3/29/2016
Soligenix (SNGX) Announces Publication Of Preclinical Efficacy Results With Dusquetide In Infectious Disease 3/29/2016
OWC Pharmaceutical Research Corp. Advances Its Multiple Myeloma Study To Animals 3/29/2016
Kolltan Pharmaceuticals Inc. To Present Preclinical Data At The 2016 AACR Annual Meeting 3/28/2016
Preclinical Efficacy Data Of Apogenix' APG101 In Myelodysplastic Syndromes (MDS) Published In Oncotarget 3/24/2016